First, while all of the targeted nanoparticles displayed a quantitative increase in tumor accumulation over the non-targeted controls from Figure 2, only the HER2-SPIO demonstrated a statistically significant difference both between the non-targeted control (p < 0.01) and also the other targeted nanoparticles (p < 0.01). This evidence concerns the gene ERBB2 and neoplasm.